ArticleResearch and practice in thrombosis and haemostasis2026
Early venous thrombus resolution in neonates/infants: retrospective review of a 20-year single institution experience.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early clot resolution in neonates: time to rethink duration of anticoagulation in neonatal catheter-related venous thromboembolism?Research and practice in thrombosis and haemostasis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Due to differences in developmental hemostasis, the management of neonatal and infant venous thromboembolism requires special consideration compared with adults and even older children. The benefits of anticoagulation to optimize thrombus resolution and prevent recurrence need to be balanced with the risks of bleeding, and recent studies support shorter courses of anticoagulation treatment for children. Objectives: Review outcomes of neonatal (age ≤28 days) and young infant (age ≤3 months) thrombi treated at a single institution over a 20-year period with the standard practice of performing an ultrasound at 2 to 4 weeks postdiagnosis and discontinuing anticoagulation with thrombus resolution. Methods: All deep vein thrombosis (DVT) diagnosed in patients ≤3 months of age between October 2003 and January 2025 were reviewed retrospectively, with arterial, superficial vein, portal vein, and/or renal vein thrombi excluded. Results: A total of 151 patients met criteria (neonates = 79 and young infants = 72), and 179 DVTs were identified. The median resolution time was 28 (IQR, 13-60) days, with a significant proportion of thrombi resolving by 2 (16.8%) and 4 (28.5%) weeks, respectively. DVTs that were more likely to resolve early included those affecting the upper limb and those that were initially partially occlusive. No significant differences in venous thromboembolism resolution were observed between cardiac versus noncardiac patients. Post-DVT treatment, the 1-year recurrence rate was low at 3.4%. Conclusion: These findings suggest a significant proportion of DVT in children aged ≤3 months of age may resolve within 2 to 4 weeks postdiagnosis, and ultrasound screening in this timeframe may be useful in limiting anticoagulation duration to reduce potential bleeding risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.